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Abstract
Background: Accurate and meaningful dose metrics are a basic requirement for in vitro screening to assess
potential health risks of engineered nanomaterials (ENMs). Correctly and consistently quantifying what cells “see,”
during an in vitro exposure requires standardized preparation of stable ENM suspensions, accurate characterizatoin
of agglomerate sizes and effective densities, and predictive modeling of mass transport. Earlier transport models
provided a marked improvement over administered concentration or total mass, but included assumptions that
could produce sizable inaccuracies, most notably that all particles at the bottom of the well are adsorbed or taken
up by cells, which would drive transport downward, resulting in overestimation of deposition.
Methods: Here we present development, validation and results of two robust computational transport models.
Both three-dimensional computational fluid dynamics (CFD) and a newly-developed one-dimensional Distorted Grid
(DG) model were used to estimate delivered dose metrics for industry-relevant metal oxide ENMs suspended in
culture media. Both models allow simultaneous modeling of full size distributions for polydisperse ENM suspensions,
and provide deposition metrics as well as concentration metrics over the extent of the well. The DG model also
emulates the biokinetics at the particle-cell interface using a Langmuir isotherm, governed by a user-defined
dissociation constant, KD, and allows modeling of ENM dissolution over time.
Results: Dose metrics predicted by the two models were in remarkably close agreement. The DG model was also
validated by quantitative analysis of flash-frozen, cryosectioned columns of ENM suspensions. Results of simulations
based on agglomerate size distributions differed substantially from those obtained using mean sizes. The effect of
cellular adsorption on delivered dose was negligible for KD values consistent with non-specific binding (> 1 nM),
whereas smaller values (≤ 1 nM) typical of specific high-affinity binding resulted in faster and eventual complete
deposition of material.
Conclusions: The advanced models presented provide practical and robust tools for obtaining accurate dose metrics
and concentration profiles across the well, for high-throughput screening of ENMs. The DG model allows rapid
modeling that accommodates polydispersity, dissolution, and adsorption. Result of adsorption studies suggest that a
reflective lower boundary condition is appropriate for modeling most in vitro ENM exposures.
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Background
Assessing the potential health risks associated with ex-
posures to the vast number and variety of engineered
nanomaterials (ENMs) entering manufacturing work-
places and now present in myriad consumer products is
a daunting task that requires fast, inexpensive and reli-
able screening strategies [1–5]. Although animal testing
may provide the most relevant and reliable assessment
of a nanomaterial’s biological activity, the associated cost
and throughput constraints, as well as humane concerns,
render this approach impractical [1, 4, 6]. A screening
approach using in vitro cell-based assays provides a lo-
gical and efficient alternative [7]. However, in vitro test-
ing has often produced results that are inconsistent with
those of corresponding in vivo studies and even of other
in vitro studies of the same ENMs [4–8]. Although the
many differences between monocultured cell and whole
animal experimental systems may account for much of
this disparity, it is likely that failure to match in vitro and
in vivo doses, as a result of inadequate characterization of
ENM powders and suspensions, and more importantly,
failure to account for transport of ENM particles or
agglomerates in suspension over time, is in part respon-
sible for these disparities [9–13].
Until recently most in vitro studies have reported dose
in terms of either an initial administered mass concen-
tration or of a total administered mass [11, 14, 15]. The
former assumes that sedimentation either does not
occur, or is negligible, and the latter assumes that it is
complete, with all of the suspended material instantly
transported to the cells at the bottom of the cell culture
well. The reality lies between these extremes, and de-
pends upon the intrinsic physicochemical properties of
the suspended material, the extrinsic properties of
suspending media, and the time course of the exposure.
Of late, greater emphasis has been placed upon achiev-
ing a better understanding of the exposures experienced
by cells in vitro, and of the measures necessary for accur-
ate and meaningful dosimetry [12, 16–20] (+1 for > =20).
These include several standardized methodologies, from
generation of stable suspensions, to accurate physical
characterization of formed agglomerates in suspension, to
appropriate modeling of the transport of particles or
agglomerates during exposure. An integrated approach for
in vitro nanodosimetry based on these methodologies is
depicted in Fig. 1.
Most industrially-relevant ENMs form agglomerates
when dispersed in liquid. The size, or size distribution,
and effective density of these agglomerates determine
their transport properties (sedimentation and diffusion
coefficients), and thus control the rate at which the ma-
terial settles, which in turn determines the ENM mass,
surface and particle number delivered to cells as a func-
tion of time [12, 16, 17]. ENM agglomeration state can
also influence the nature and extent of biological effects
[21, 22]. As we have recently reported, the agglomerate
size distribution, and more importantly the agglomerate
stability (re-agglomeration rate), are dependent upon
the dispersion protocol and properties of the dispersant
[11, 17]. Initial sonication of ENM powder in deionized
water at or above an ENM-dependent critical delivered
sonication energy (DSEcr), followed by dilution into cul-
ture media, produces suspensions with remarkably stable
size distributions, whereas the size distributions of suspen-
sions created at less than DSEcr can change substantially
(suggesting re-agglomeration) over time [11].
Once a stable suspension is created, particle sizes are
typically determined by either dynamic light scattering
(DLS), disk centrifugation, or tunable resistive pulse sens-
ing technology (TRPS) [13] and are routinely reported in
in vitro studies. Effective density of agglomerates can differ
Fig. 1 Integrated nanodosimetry approach overview. Methodologies
required for accurate nano-dosimetry include: 1) standardized
dispersion preparation protocols, 2) detailed colloidal suspension
characterization including size and effective density of formed
agglomerates, and 3) computational modeling of transport based on
agglomerate, media and system properties. Standardized dispersion
protocol to maximize stability of agglomeration state includes
sonication of nanomaterial in deionized water to particle-specific
critical dispersion sonication energy (DSEcr), followed by dilution into
final application media. Dispersions are analyzed by DLS to
determine agglomerate hydrodynamic diameters, and by VCM to
determine agglomerate effective density. Transport modeling to
determine dose metrics requires dH from DLS and ρEV from VCM, as
well as media properties (viscosity, ηm and density, ρm) and system
parameters (temperature, Τ and media column height, h). Available
computational transport models include VCM-ISDD, computational
fluid dynamics (CFD) and Distorted Grid (DG, introduced in this
report) models. Possible output dose metrics include exposure
concentrations in the cell microenvironment at the bottom of the
well (including mass, surface area and particle number), fractional or
absolute deposition (in terms of mass, surface area and particle
number), as well as concentration as a function of vertical position
within the well (concentration profile)
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from bulk ENM density by many fold due to the forma-
tion of protein coronae and intra-agglomerate trapping of
media [12, 17]. Despite its important influence on trans-
port and thereby on delivered cellular dose, it is rarely
measured and reported in published in vitro studies. This
is primarily due to methodological limitations that
until recently required expensive instrumentation such
as an Analytical Ultracentrifuge (AUC). The volumet-
ric centrifugation method (VCM), recently developed
by the authors, provides a fast and practical alterna-
tive for determination of effective density of ENMs in
suspension [12].
The first computational fate and transport model devel-
oped for ENM dosimetry was the In vitro Sedimentation,
Diffusion and Dosimetry model (ISDD) reported by
Hinderliter et al. [16]. The ISDD model utilizes an analyt-
ical solution of the Mason Weaver equation to determine,
in a suspension column of a given height, and a given con-
centration of particles or agglomerates of a given diameter
and density, the per area mass, surface area, and number
of particles, as well as the fraction of total suspended ma-
terial deposited as a function of time. This provided a
ground-breaking improvement in dosimetry accuracy and
enabled meaningful comparisons and safety hazard rank-
ings among ENMs of different physiochemical properties.
The ISDD initially estimated effective density using the
Sterling equation, based on a theoretical fractal model and
estimated fractal dimensions for ENM agglomerates [23].
More recently the ISDD has been modified to utilize the
empirically-based and more accurate VCM to measure ef-
fective density, with the integrated approach now referred
to as VCM-ISDD [17].
Although the VCM-ISDD model importantly allows
assessment of relative deposition over time, it employs a
perfectly adsorptive (sticky) lower boundary condition,
the result of which is the prediction of complete depos-
ition for all materials, within a few hours to several days,
depending on particle size and density. This is inconsist-
ent with our observations of nanoparticle suspensions
over extended periods of time (months). With the excep-
tion of cases in which particles are sufficiently large or
dense that the role of diffusion relative to sedimentation
is negligible, or cases in which strong adsorption or up-
take by cells creates a perpetual sink at the bottom of
the well, the concentration gradient created by sedimen-
tation would drive net diffusion upward, such that an
equilibrium is eventually obtained, and complete depos-
ition would not occur. The VCM-ISDD model is also
limited to modeling transport of a single agglomerate
size at a time. Although transport of a polydisperse sus-
pension can be modeled by summing results of individ-
ual simulations for each size category, this is unwieldy
for high-resolution size distributions, which from DLS,
for example, may contain up to 300 size species, and
moreover it precludes the possibility of adjusting for dy-
namic cross-species interactions and effects on transport
parameters. In addition, output from the VCM-ISDD is
limited to the absolute or fractional deposition over time,
and does not provide concentration metrics, which more
closely represent what cells “see.” Finally, the VCM-ISDD
does not provide mechanisms for modeling of ENMs that
undergo dissolution with time, which can not only reduce
deposition of solid ENM and add a dissolved dose compo-
nent, but may also dynamically change relevant transport
parameters of particles. Thus although the VCM-ISDD
provides useful measures and relative comparisons of
transport and effective dose among different materials, a
number of refinements are needed.
Here we present results from two advanced numerical
transport models that address these issues: 1) a new
one-dimensional iterative distorted grid (DG) model,
and 2) the gold standard three-dimensional computa-
tional fluid dynamics (CFD) approach. Each of these
models provide deposition as well as concentration of
ENMs as a function of time, both at the bottom of a cul-
ture well (the cell microenvironment) and as a function
of vertical position within suspension column. Both
models accommodate simultaneous simulation of poly-
disperse suspensions. The DG model further provides
modeling of particles that undergo dissolution over time,
as well as a variable ‘stickiness’ boundary condition at
the bottom, implemented using a Langmuir isotherm
process. As we demonstrate below, the results of the dis-
torted grid model, which was implemented in MATLAB,
and typically runs in a few minutes on standard desktop
computer, are in close agreement with those from CFD.
Finally, we validated the DG model by experimentally
measuring particle deposition profiles in thinly-sectioned
frozen columns of industry-relevant ENM suspensions.
Results
Comparison of Distorted Grid and CFD model simulations
The Distorted Grid (DG) model is based on a model
previously developed for analysis of protein systems via
their behavior in an ultracentrifuge [24–30], which was
adapted for particle transport and implemented in
MATLAB. In this model the column of suspended parti-
cles is divided into n compartments separated by n + 1
boundaries, and successive brief rounds of simulated
sedimentation and diffusion are performed, with transfer
of suspended material between compartments. A de-
tailed mathematical description of the DG model design
is provided in the methods section.
In the Computational Fluid Dynamics (CFD) model,
particles are initially assigned to compartments of a
3-dimensional grid representation of the suspension
column, and a solution of the Navier–Stokes equation
is used to calculate the movement of individual
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particles between compartments. A complete descrip-
tion of the CFD model used in these studies is
presented in methods.
Concentration profiles (ENM mass concentrations as a
function of distance from the bottom of the well) at
12 h, and fractional deposition (fraction of mass present
in the bottom 10 μm of the well) as a function of time,
as computed by the DG and CFD models, for CeO2(in
RPMI + 0.5 % BSA) and SiO2 (in PBS + 0.1 % BSA), are
compared in Fig 2a. A thickness of 10 μm was somewhat
arbitrarily chosen for the disk at the bottom of the well
representing the cell microenvironment. We based this
choice on thickness typically observed for typical adher-
ent cells in culture. However both the DG and CFD
models allow this thickness value to be specified by the
user, and smaller or larger thicknesses may be appropri-
ate depending on the type of cell or system being stud-
ied. Properties of ENM powders and of their forms in
liquid suspension, including effective densities (ρEV),
are given in Table 1. The volume-weighted size (dH)
distributions (calculated from particle number distribu-
tions from DLS as described in methods) of liquid sus-
pensions used in these simulations are shown in
Additional file 1: Figure S3.
Simulation results for CFD and DG results for CeO2
and TiO2 are nearly identical (within <5 %) (Fig. 2). Be-
cause the CFD model tracks movement of each individual
particle it is highly computationally-intensive, which
places practical constraints on the number of particles,
and thus the model geometry and concentration of ENMs,
that can be simulated in a reasonable time with available
computational resources. Thus, in our CFD simulations
we employed a column height of 1 mm, and concentra-
tions of 0.1 mg ml−1 for CeO2 and 0.001 mg ml
−1 for
SiO2, resulting in a total of approximately 3.8 × 10
5 parti-
cles in each case. Even at these low values the CFD
Fig. 2 Distorted Grid model cryosection validation. a Concentration profiles and material fraction deposited (present in the bottom 10 μm of the
cell) predicted by the DG model are compared with those obtained from CFD for CeO2 and SiO2. (C0 = 0. 1 mg ml
−1 for CeO2 and 0.001 mg ml
−1
for SiO2, column height = 1 mm, dH = volume size distribution from DLS, see Additional file 1: Figure S2). b Concentration profiles predicted by
the DG model are compared with those obtained from corresponding cryosectioned samples for CeO2 (24 h), TiO2 (64 h) and Fe2O3 (24 h)
nanomaterials (C0 = 0.1 mg ml
−1, column height = 10 mm, dH = volume size distribution from DLS (Additional file 1: Figure S2))
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simulations for CeO2 and SiO2 required, respectively,
12 and 48 h of compute time on a multi-processor
supercomputer. By contrast, the corresponding simu-
lations using the DG model were each completed in
less than a minute on a standard single-processor PC.
The results of both the DG model and CFD can be af-
fected by selection of compartment (DG) or grid (CFD)
size. To ensure grid size-independence, simulations were
performed over a range of compartment sizes for SiO2.
Whereas the final predicted deposition or bottom of
column concentration increased substantially as compart-
ment and grid sizes were decreased from 50.0 to 5.0 μm,
results were independent of compartment/grid sizes for
values less than 5 μm (data not shown). Likewise, simula-
tions were run over a range of iteration time intervals to
verify that results were independent of time interval be-
tween 0.1 to 1.0 seconds.
Experimental Validation of Distorted Grid model by
frozen section analysis
Concentration profiles predicted by the DG model were
compared with those obtained from frozen sections of
corresponding columns of nanoparticle suspensions. Col-
umns of Fe2O3, CeO2 and TiO2 suspensions (powder and
liquid suspension properties shown in Table 1) were flash
frozen and cryosectioned following incubations (to allow
transport) at room temperature of 24 h for Fe2O3 and
CeO2, and 64 h for TiO2. Material concentrations within
individual sections were determined by spectrophotometry
using standard curves prepared from frozen-and-thawed
suspensions of known mass concentrations. The process
for creating suspension columns and for obtaining cryosec-
tioned slice concentrations is described in the methods
section and illustrated in Additional file 1: Figure S2. For
all three ENMs tested the concentration profile predicted
by the DG model was in close agreement with that
obtained from frozen sections (Fig. 2b).
DG model-derived mass, particle number and surface
dose metrics
Although ENM mass concentration and deposition per
unit area are the most commonly-used in vitro dose
metrics, it is also important to consider exposures in
terms of particle number and surface area [9, 10, 15].
Not only is it possible that biological effects may in some
cases track more closely with these values, but because
of differences in agglomerate formation the relative mag-
nitudes of number and surface area metrics for suspen-
sions of different materials undergoing transport may
differ substantially from the corresponding mass metrics.
The DG model provides both concentration and de-
position outputs in terms of number of particles
(N ml−1 and N cm−2) and ENM surface area (cm2 ml−1
and cm2 cm−2). Calculation of number and surface area
metrics from mass concentration and deposition metrics
are described in methods.
DG model-derived mass, particle number and ENM sur-
face area dose metrics as a function of time (from 0 to
120 h) for four ENMs (SiO2, Fe2O3, TiO2 and CeO2), with
initial mass concentration, C0 = 0.1 mg ml
−1, suspension
column height of 3 mm, and volume averaged particle
diameter (〈dH〉v x, Table 1) are shown in Fig. 3. Because
we define deposition (not equivalent to binding, which is
discussed below) as the total mass, particle number or sur-
face area in the bottom 10 μm of the column, it is calcu-
lated as the product of concentration and the volume of
that disk. The shapes of the concentration curves are
therefore identical to those of the corresponding depos-
ition curves, differing only in scale and units, and both
can be represented in the same graph using appropriately
scaled axes (Fig. 3). Interestingly, the relative magnitudes
and ranking of the four materials by concentration (or de-
position) differs for the three different classes of metrics.
For example, mass concentration and deposition are at all
time points greatest for CeO2 and smallest for SiO2,
whereas particle number and surface area concentration
and deposition of CeO2 are much less than those of SiO2.
These differences are not a result of transport differences
per se, but are rather due to differences in agglomeration
state. Specifically, since the agglomerates of SiO2
(〈dH〉v =149.9 nm) are much smaller than those of CeO2
(〈dH〉v = 982.1 nm), the total number and surface area of
SiO2 for a given mass concentration are considerably
greater than the corresponding values for CeO2.
Table 1 ENM properties
Material SSA(m2 g−1) dBET(nm) Media dHv(nm) PdI ρENM(g cm
−3) ρEV(g cm
−3)
VENGES SiO2 147 18.6 PBS + 0.1 % BSA 149.9 0.175 ± 0.013 2.648 1.564 ± 0.009
VENGES Fe2O3 41.5 27.6 RPMI + 10 % HS 234.5 0.755 ± 0.203 5.242 1.335 ± 0.000
VENGES CeO2 144 5.4 RPMI + 0.5 % BSA 982.1 0.310 ± 0.091 7.215 1.420 ± 0.004
EVONIK TiO2 50 21 RPMI + 10 % HS 397.8 0.233 ± 0.018 4.230 1.251 ± 0.005
Alfa Aesar ZnO 17 63 RPMI + 10 % FBS 307.0 0.303 ± 0.122 5.606 1.650 ± 0.070
SSA: (specific surface area) by nitrogen adsorption/Brunauer-Emmett-Teller (BET) method. dBET : primary particle diameter determined from SSA, dXRD : particle
diameter as determined by X-ray diffraction, <dH > v: mean hydrodynamic diameter from DLS volume distribution, ρENM: bulk ENM material density, ρEV: effective
density estimated by volumetric centrifugation.
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Fig. 3 (See legend on next page.)
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Effect of particle-cell binding/adsorption – well bottom
boundary condition
The data presented to this point, including those from
validation experiments, were obtained using a reflective
boundary condition at the bottom of the well: particles
arriving at the bottom were not bound or removed from
the system, but remained present, undergoing Brownian
motion, and contributing to the concentration gradient
driving diffusion. The opposite extreme boundary condi-
tion is one in which all particles that reach the bottom of
the well adhere to the cells there, effectively removing
them from the concentration gradient. The real world
condition likely lies somewhere between these two ex-
tremes, and is ENM-, media-, and cell type-dependent.
Some of the ENM agglomerates that reach the cell micro-
environment in an in vitro exposure system may adhere to
cells, or in the case of phagocytic cells may be internalized,
which in either case would eliminate their contribution to
the diffusion gradient opposing sedimentation, and
thereby increase the net rate of transport toward the bot-
tom of the well. Quantification of particle-cell binding and
uptake is an emerging research area [22] and a complex
topic that will be addressed in future work, but because
binding can, as we will demonstrate, have a large effect on
net transport, it is important to incorporate this variable
in fate and transport models. Initially we can employ rea-
sonable estimates of binding, based on our understanding
of the particle- and protein-protein interactions that are
likely to be involved, which can be later refined as specific
data for particle-cell binding kinetics become available.
Accordingly, an adsorption strength (stickiness) parameter
was incorporated in the DG model to simulate boundary
conditions with variable levels of adsorption at the bottom
of the well. This is implemented as a Langmuir isotherm
process [31], in which adsorption is characterized by the
equilibrium dissociation constant, KD, as described in the
methods section.
The effect of cellular adsorption on total (free + cell
bound) ENM mass concentration in the lower 10 μm ex-
posure volume, as well as the cell-bound ENM mass per
unit well bottom area (mg cm−2) for SiO2, Fe2O3 , and
TiO2 (all at C0 = 0.1 mg ml
−1, for a 3 mm column
height, using volume averaged particle diameter (〈dH〉v,
Table 1) ), with various values of KD, are shown in Fig. 4.
It is clear from these results that very small values of KD,
in the nanomolar range, produce sizeable changes in
exposure concentrations (at the bottom of the well). Fur-
ther decreases in KD did not increase predicted well bot-
tom concentrations beyond those for the smallest KD
values shown. Such small values correspond to high-
affinity binding typical of specific protein interactions,
and are several orders of magnitude smaller than the
millimolar or micromolar values typical of non-specific
interactions [32–34]. Interactions between ENM ag-
glomerates and cell surface biomolecules are most likely
of the latter, weak non-specific type. We therefore as-
sume that in most cases the effect of particle-cell
binding on transport is negligible, and the reflective
boundary condition was therefore used in all other
simulations reported here.
Because the VCM-ISDD model imposes a perfectly
sticky (sink) lower boundary condition, we would expect
it to predict faster and more complete deposition of ma-
terial than the DG model with a reflective boundary,
particularly for smaller particles, where diffusion plays a
relatively larger role. To test this we compared dose
metrics predicted by the DG and VCM-ISDD models for
four materials (SiO2, Fe2O3, TiO2 and CeO2), at initial
mass concentration, C0 = 0.1 mg ml
−1, suspension col-
umn height = 3 mm, and volume averaged particle diam-
eter (〈dH〉v, Table 1). The results of these simulations are
shown in Additional file 1: Figure S4. Whereas both
models are in almost perfect agreement regarding the
transport of CeO2 (〈dH〉v =982.1 nm, ρEV =1.420 g cm
−3),
they provide slightly different predictions for
TiO2(〈dH〉v =397.8 nm, ρEV =1.251 g cm
−3), and strongly
different predictions for Fe2O3 (〈dH〉v =234.5 nm, ρEV
=1.335 g cm−3) and SiO2 (〈dH〉v =149.9 nm, ρEV
=1.564 g cm−3). Specifically, the VCM-ISDD model
predicts deposition fraction approaching 1.0 for all
materials, whereas the DG model predicts complete
deposition only in the case of CeO2, which forms
the largest agglomerates. For the three other mate-
rials the DG model predicts that the deposited frac-
tion approaches an equilibrium value well below 1.0,
and less than 0.2 for SiO2, which forms the smallest
agglomerates.
Effect of agglomerate size and density on dosimetry
The sedimentation velocity, vs, of a particle of hydro-
dynamic diameter dH (m) under gravity is defined as
(See figure on previous page.)
Fig. 3 DG model output dose metrics. DG model dose metric output data (in bottom 10 μm) for SiO2, Fe2O3, TiO2 and CeO2 nanomaterials
(C0 = 0.1 mg ml
−1, column height = 3 mm, dH = volume-averaged mean (Table 1), reflective boundary condition) from 0 to 120 h. a ENM
mass concentration (mg ml−1) and mass deposited per well bottom surface area (mg cm−2). b ENM surface area concentration (cm2 ml−1)
and ENM surface area deposited per unit floor surface area (cm2 cm−2). c Particle number concentration (N ml−1) and particle number
deposited per unit area (N cm−2)
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Fig. 4 Effect of binding on DG-predicted dose metrics. Effect of particle/agglomerate binding to cells (well bottom) on DG model dose metrics
for SiO2 (a, b), Fe2O3 (c, d), and TiO2 (e, f). For all simulations C0 = 0.1 mg ml
−1, column height = 3 mm, and dH = volume-averaged mean
(Table 1). Langmuir isotherm adsorption was used to model binding of agglomerates to the well bottom at various values of the dissociation
constant KD. a, c, e Exposure mass ENM concentration, Cbottom (mg cm
−3 in bottom 10 μm, including ENM within both bound and free agglomerates).
b, d, f Mass of ENM bound per well bottom area (mg cm−2)
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vs ¼ gðρEV−ρmediaÞd
2
H
18η
ð1Þ
where g is the acceleration due to gravity, g (m s−2), ρEV
is the effective density of the particle (kg m−3), ρmedia is
the media density (kg m−3), and η is the media dynamic
viscosity (kg m−1 s−1). The rate of mass transport by
diffusion is proportional to the diffusion coefficient D
(m2 s−1), which is defined by the Stokes-Einstein
equation as:
D ¼ kBT
3πηdH
ð2Þ
in which kB is the Boltzmann constant (kg m
2 s−2 K−1),
T is the absolute temperature (°K), and η is the media
dynamic viscosity (kg m−1 s−1). Sedimentation velocity is
thus proportional to the difference between the densities
of the sedimenting particle and the suspending media,
and to the square of particle diameter (Eq. 1), whereas
diffusion is independent of density and linearly related
to particle diameter (Eq. 2). Transport modeling should
therefore predict that more dense and particularly
larger particles concentrate more rapidly at the bot-
tom of a column of suspension than less dense and
smaller particles.
We simulated transport using the DG model for hypo-
thetical particles of constant size (dH = 150 nm) ranging
in density from ρEV =1.1 to 2.5 g cm
−3, and for particles
of constant density (ρEV =1.5 g cm
−3) ranging in size
from dH = 150 to 500 nm. Results of these simulations
are shown in Fig. 5. As expected, for particles of constant
size, predicted transport was more rapid for particles
of higher density, and likewise for particles of constant
density, predicted transport proceeded more rapidly for
larger particles.
Effect of Polydispersity
Since most ENM suspensions are polydisperse, it is im-
portant to account for the effect of polydispersity when
modeling transport. The DG model allows input of a
particle size distribution consisting of paired arrays of
particle hydrodynamic diameters and fractional contri-
butions to the total agglomerate mass (e.g., from DLS).
We compared concentration profiles and dose metrics
obtained from the DG model using volume-weighted
polydisperse size/fraction arrays with those obtained
using volume-weighted average sizes (dHv), for SiO2,
Fe2O3, TiO2 and CeO2 suspensions (24 h simulations,
C0 = 0.1 mg ml
−1, column height = 3 mm, volume
averaged particle diameters shown in Table 1, volume-
weighted distributions shown in Additional file 1: Figure
S3). The results, shown in Fig. 6, reveal substantial
differences between modeling with mean size and
modeling using size/fraction arrays. In the case of
CeO2, for example, well bottom concentration and
fraction deposited reached maximum plateaus at 4 h
when transport was modeled using an average diam-
eter, but had only reached approximately two thirds
maximum at the same time when modeled using the
full size distribution. In the Case of TiO2, average size
simulations resulted in higher predicted concentration
and deposition at early time points, but lower pre-
dicted values at later times, relative to modeling with
polydispersity. For both Fe2O3 and SiO2, average size
simulations substantially under-predicted concentra-
tion and deposition at all times relative to the poly-
disperse simulations.
Effect of solubilization
For some nanomaterials it is important to account for
solubilization of the material over time during in vitro ex-
posure. Xia et al. (2008) [35] found that for 10 μg ml−1
(122.8 μM) suspensions of ZnO in DMEM with 10 % FBS,
up to 74 % of the ZnO was solubilized within 10 minutes
(corresponding to a dissolved concentration of 90 μM),
and that in water initial dissolution was less extensive
(20 μM), but continued linearly over 3 h to a maximum of
60 μM. Solubilization of ENM during an in vitro exposure
not only reduces the concentration of solid ENM to which
cells are exposed, and adds an exposure of solubilized
or ionized material, but may also change the trans-
port properties of agglomerate species. Although more
complex relationships between solubilization and ag-
glomerate state and agglomerate transport properties
are possible, as a first approximation we modeled
solubilization as a reduction of agglomerate size in
proportion to the extent of dissolution.
Solid ENM mass exposure concentration (in bottom
10 μm) and dissolved ENM concentrations predicted by
DG under various solubilization scenarios for ZnO (C0 =
0.01 mg ml−1, column height = 3 mm, dH = volume-
averaged mean (Table 1)) for 24 h transport duration are
shown in Fig. 7. ZnO solid mass exposure concentration
(mg ml−1 in bottom 10 μm of well) and solubilized ZnO
concentration (mg ml−1) for initial solubilization to 0,
30, 60 and 90 μM (0.0, 2.442, 7.327 and 4.885 μg ml−1,
dissolved fraction = 0.0, 0.2442, 0.4485, and 0.7327) with
no further dissolution during transport are shown in
Fig. 7a and b. Solid mass and dissolved exposure con-
centrations with initial solubility of 20 μM (1.63 μg/ml,
dissolved fraction = 0.163) and continuous constant dis-
solution of 0, 2, 4 and 6 μM h−1 (0.0, 0.16, 0.32 and
0.48 μg ml−1 h−1, fraction dissolved = 0.0, 0.016, 0.032
and 0.048 h−1) are shown in Fig. 7c and d. Solid and dis-
solved exposure mass concentrations with initial solubil-
ity of 20 μM and further linear increase in dissolution
up to 12 h to maximum total dissolution of 20, 30,
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60 and 90 μM (1.63, 2.442, 7.327 and 4.885 μg ml−1,
dissolved fraction = 0.163, 0.2442, 0.4485, 0.7327) at
12 h, and remaining constant thereafter, are shown in
Fig. 7e and f.
Discussion
We have experimentally validated the predictions of the
DG model by analysis of frozen and sectioned columns of
test materials, and shown that the results of the DG model
compare closely with the CFD model. Although CFD may
be considered the gold standard for transport modeling, it
is computationally-intensive, requiring expensive software
and hardware, and long compute times, whereas the DG
model requires only MATLAB, and a typical personal
computer, and runs in a few minutes or less.
We have demonstrated here that the suspension-cell
boundary condition at the bottom of the well is a critical
determinant of predicted transport and dose. With a re-
flective boundary, sedimentation generates a gradient
that drives diffusion upward, which reducing net down-
ward transport and leading to an equilibrium gradient
beyond which no further net transport occurs. Con-
versely, when the boundary is modeled as perfectly ad-
herent, particles are sequestered to a greater or lesser
extent depending on the value of KD, reducing, and in
the extreme case inverting the diffusion-driving gradient,
and thus increases net transport toward the bottom. Our
results show that values of KD in the nanomolar range
or lower are required to appreciably affect delivered dose
metrics (Fig. 4). KD values of this order are typical of
specific protein-protein interactions. For example, KD
for mouse IgG anti-biotin antibody binding to biotin-
BSA targets was found to be 2.3 nM [36], and binding of
wheat germ agglutinin to epithelial cell glycoproteins
has been reported as 0.32 μM [37]. By contrast, non-
specific protein-protein interactions are considerably
weaker, with KD values in the millimolar range [32–34].
Interactions between nanoparticle corona proteins and
cell surface biomolecules in cell culture would likely fall
predominantly into the latter non-specific category, and
cell surface adsorption of particles would therefore not
be expected to significantly alter transport. Moreover,
Fig. 5 Effect of diameter and effective density on DG-predicted dose metrics. a and b, DG model output as a function of effective particle density
(ρEV from 1.1 to 2.5 g cm−3) at constant dH (150 nm). a, Well concentration profiles at 120 h. b, Fraction of material deposited and well bottom
(bottom 10 μm) concentration (mg ml−1) from 0 to 120 h. c, from 0 to 120 h. c and d, DG model output as a function of particle/agglomerate
diameter (dH from 50 to 500 nm) at constant ρEV (1.5 g cm−3). c, Well concentration profiles at 120 h. d, Fraction of material deposited and well
bottom (bottom 10 μm) concentration (mg ml−1) from 0 to 120 h
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the same proteins constituting the ENM protein corona
and participating in interactions with cell surface bio-
molecules, would also be highly abundant in free form
within the media. To the extent that significant affinity
existed between these proteins and cell surface biomole-
cules, the relatively abundant free protein molecules
would occupy most of the available binding sites. In
addition, we previously showed that when epithelial cells
were incubated with metal oxide and silica-coated metal
oxide ENMs [38] less than 0.1 % of the suspended ma-
terial was either associated with or had transmigrated
through cells after 24 h [18], consistent with non-
specific binding and negligible effects of adsorption on
transport. These data and considerations taken together
suggest that a reflective boundary condition is most
likely for suspensions of most industry relevant metal
and metal oxide ENMs suspended in culture media.
Nevertheless, further work is needed to fully assess the
role of adsorption and uptake under various conditions
and with various materials and cells. We have previously
shown, for example, that in the absence of a protein
corona (i.e. in protein-free media), metal oxide ENM
agglomerates adhere more tightly to cell surfaces than
they do when protein is present [21]. Such interactions
between naked metal or metal oxide particles and cell
surface proteins could conceivably obtain KD values
sufficiently small as to affect transport. Likewise, con-
formational changes in serum proteins caused by
ENM adsorption could potentially increase their affin-
ity for cell surface proteins, leading to greater binding
and uptake of ENMs [39]. Further investigation to as-
sess KD for various ENM/cell systems are underway in
our lab.
The DG model provides accurate modeling of transport
for polydisperse suspensions by treating particle size as a
pair of arrays (diameter and corresponding fraction of
total mass), calculating transport of each size species sep-
arately, and summing the resulting mass concentrations
over all species. As might be expected, and shown in
Fig. 6, results obtained using polydisperse size distribu-
tion were in most cases substantially different from
those obtained using a volume-weighted mean size.
These differences were considerable for all materials
examined, in spite of the relatively small polydisper-
sity indices (PdI ≤ 0.3) measured by DLS for three of
the four ENMs (Table 1). Although the differences for
some materials at certain time points were negligible
(e.g. CeO2 at 24 h and TiO2 at 12–15 h), it is clear
that taking polydispersity into consideration improves
accuracy of predicted dose metrics.
Fig. 6 Effect of polydispersity on DG-model output. Comparison of DG-predicted fraction of mass deposited (fD) or exposure concentrations
(mg ml−1 in bottom 10 μm of well) from 0 to 24 h for mean dH (Table 1) and volume size distribution from DLS (Additional file 1: Figure S3) for
a, CeO2, b, TiO2, c, Fe2O3 and d, SiO2 ENMs (C0 = 0.1 mg ml
−1, column height = 3 mm, reflective boundary condition (no binding))
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We should note that the effective density obtained by
VCM and used in these simulations is an average density
across all agglomerates, and it is likely that a distribution
of effective densities is in fact superimposed upon the ag-
glomerate size distribution. In addition, we have assumed
that the composition and effective density of agglomerates
are constant over the course of the simulated incubation.
Although the close match between simulation and valid-
ation measurements presented here suggest that these
approximations are reasonable, further studies to provide
more detailed effective density characterization as a func-
tion of time and size are warranted.
In a recently-proposed dosimetry model, dynamic ag-
glomeration of silver nanoparticles was estimated using
stochastic modeling, based upon theoretical collision
rates and estimated attractive forces [40]. Though prom-
ising, the detailed physicochemical characterization re-
quired for these estimates are not readily obtainable for
Fig. 7 Effect of ENM solubilization on DG-predicted dose metrics. Solid ENM mass exposure concentration (in bottom 10 μm) and dissolved ENM
concentrations predicted by DG model under different solubilization scenarios for ZnO (C0 = 0.01 mg ml
−1, column height = 3 mm, dH = volume-
averaged mean (Table 1)) for 24 h. a, b, ZnO solid mass exposure concentration (mg ml−1 in bottom 10 μm of well) and solubilized ZnO concentration
(mg ml−1) for initial solubilization to 0, 30, 60 and 90 μM (0.0, 2.442, 7.327 and 4.885 μg ml−1, dissolved fraction = 0.0, 0.2442, 0.4485, and 0.7327) with
no further dissolution during transport. c, d, solid mass and dissolved exposure concentrations with initial solubility of 20 μM (1.63 μg/ml, dissolved
fraction = 0.163) and continuous constant dissolution of 0, 2, 4 and 6 μM h−1 (0.0, 0.16, 0.32 and 0.48 μg ml−1 h−1, fraction dissolved = 0.0, 0.016, 0.032
and 0.048 h−1), e, f, solid and dissolved exposure mass concentrations with initial solubility of 20 μM and further linear increase in dissolution up to
12 h to maximum total dissolution of 20, 30, 60 and 90 μM (1.63, 2.442, 7.327 and 4.885 μg ml−1, dissolved fraction = 0.163, 0.2442, 0.4485, 0.7327) at
12 h and remaining constant after 12 h.
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the vast numbers of ENMs that require testing. Further-
more, we have previously shown that when ENM sus-
pensions are prepared by sonication in DI water above
critical delivered sonication energy (DSEcr), followed by
dilution into culture media, the size distributions of the
resulting suspensions are stable over time [11]. However,
in cases where substantial concentration- or time-
dependent changes in agglomeration state occur, corre-
sponding adjustments to the model could easily be
made, incorporating empirical measurements of agglom-
eration state over time and/or concentration, rather than
relying upon theoretical estimates. Because of the itera-
tive and compartmental design of the DG model, it is
well suited to such modifications. Indeed, the associating
protein system-transport modeling for which its ante-
cedent was designed includes re-calculation of molecular
species concentrations (based on stoichiometry, associ-
ation constants and the law of mass action) at the end of
each iteration [24–30]. An analogous approach could be
employed to accommodate concentration or time-
dependent changes in ENM agglomeration state.
The majority of ENMs are insoluble in aqueous solu-
tion, but when dissolution does occur, as it does with
ZnO, this must be accounted for in dosimetry and trans-
port modeling. Although it may be possible to theoretic-
ally estimate rates of dissolution over time in some
specific cases [40], empirical measurements of ENM dis-
solution by ICP-MS, such as those reported by Xia et al.
for ZnO [35], can readily be used to obtain dynamic dis-
solution data that can then be incorporated in to the
transport model. In addition to decreasing solid ENM
concentrations, solubilization may affect the size or dis-
tribution of sizes of agglomerates. The DG model allows
specification of initial dissolution as well as either a con-
stant dissolution rate or dissolution over a specified time
to maximum fraction (Fig. 7). Beyond initial dissolution,
assumed to have occurred prior to characterization of
the suspension, further dissolution was modeled as a de-
crease in size of agglomerates corresponding to the de-
crease in mass. Additional studies to characterize size
distribution over time for soluble materials will be help-
ful in refining the model for transport of such materials.
Conclusions
In summary, both the CFD and the newly-developed DG
models provide versatile and robust tools for accurately
determining in vitro ENM concentration and deposition
metrics over time. The DG model builds upon important
earlier contributions in this area, allowing nanotoxicolo-
gists to account for polydispersity and solubilization of
ENMs in suspension, as well as the effect of particle-cell
binding at bottom of the well. Such advanced fate and
transport models will enable nanotoxicologists to develop
integrated and standardized dosimetric approaches, and
will help to improve the accuracy and reliability of in vitro
toxicological assays for engineered nanomaterials.
Methods
Nanomaterials and characterization.
ENMs investigated are listed in Table 1. SiO2, Fe2O3,
and CeO2 ENM powders were generated in-house by
flame spray pyrolysis using the Harvard Versatile
Engineered Nanomaterial Generation System as previ-
ously described (VENGES) [41, 42]. TiO2 and ZnO ENM
powders were obtained from EVONIK (Essen, Germany)
and Alfa Aesar (Ward Hill, MA, USA) respectively.
Specific surface area, SSA, was determined by the nitro-
gen adsorption/Brunauer-Emmett-Teller (BET) method
using a Micrometrics Tristar 3000 (Micrometrics, Inc.,
Norcross, GA, USA). Equivalent primary particle diameter,
dBET, was calculated, assuming spherical particles, as
dBET ¼ 6SSA ρp
ð3Þ
where ρp is the particle density, which was obtained for
each particle from the densities of component materials, at
20 °C, reported in the CRC handbook of Chemistry and
Physics [43]. Particle crystal size and diameter was also de-
termined by X-ray diffraction using a Scintag XDS2000
powder diffractometer (Scintag Inc., Cupertino, CA, USA),
reported here as dXRD.
ENM dispersal and characterization in suspension
Dispersions were prepared based on a protocol recently
developed by the authors [11]. Briefly, sonication was
performed in deionized water (DI H2O) using the critical
dispersion sonication energy (DSEcr), which was deter-
mined as previously described for each ENM [11]. ENMs
were dispersed at 5 mg cm−3 in 3 ml of solute in 15 ml
conical polyethylene tubes, by sonication with a cup
horn Branson Sonifier S450-A (Branson Ultrasonics
Corporation, Danbury, CT) (maximum power output
400 W at 60 Hz, continuous mode, output level 3, power
delivered to sample: 1.25 W). Stock DI H2O suspensions
were then diluted to final concentrations in either RPMI +
10 % FBS or PBS + 0.5 % BSA and vortexed for 30 seconds.
Dispersions were analyzed by DLS for determination of
hydrodynamic diameters (dH) and polydispersity indices
(PdI) using a Zetasizer Nano-ZS (Malvern Instruments,
Worcestershire, UK).
Effective density by volumetric centrifugation
method (VCM)
Effective densities of ENMs were determined as previously
described [12]. Briefly, 1.0 ml samples of 100 μg cm−3 sus-
pensions of ENMs were dispensed into packed cell volume
(PCV) tubes (Techno Plastic Products, Trasadingen,
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Switzerland) and centrifuged at 2,000 × g for one hour to
pellet the suspended material in the bottom (capillary) of
the PCV tube.
Agglomerate pellet volumes, Vpellet, were measured
using the easy-measure device from the PCV tube
manufacturer. This device roughly resembles a thick
steel ruler. The front face is etched along the top
edge with graduations at 0.025 μl intervals from 0 to
5 μl. On the back face is a shelf that declines from
near the top edge of the ruler at the left end, to near
the bottom edge at the right end. The PCV tube rests
with its bottom (capillary) end on the ramp, while be-
ing held in a sliding holder that wraps around the
ruler. The front of the holder contains a lens that
magnifies the view of the PCV tube capillary and the
ruler graduation marks. The tube in its holder is slid
along the ramp until the top edge of the pellet in the
capillary is aligned with the top edge of the ruler, and
the volume is read from the graduation mark coinci-
dent with that horizontal position.
Media densities were calculated from the mass of a
50 ml sample by subtracting the weight of a 50 ml volu-
metric flask from the weight of the same flask containing
50 ml of media. Effective agglomerate densities were cal-
culated from Vpellet values of triplicate samples for each
ENM, assuming a stacking factor, SF, of 0.634.
Validation by frozen sections
Cylindrical receptacles for suspensions were created
as follows. Polypropylene 15 ml conical tubes were
cut down to approximately 5 cm in height and lined
with polyethylene film. Approximately 3 ml of liquid
paraffin wax was dispensed into each tube. A smooth
7 mm diameter hardwood dowel was inserted verti-
cally into the paraffin in each tube, and maintained
perpendicular to the bench surface until cooled, after
which the dowel was removed, leaving a smooth cy-
lindrical cavity of the same dimensions (7 mm in
diameter, ~4 cm in height).
Nanomaterial suspensions were dispensed into the
paraffin receptacles to create a column 10 mm in height
(184 μl for the cylinder 7 mm in diameter), tubes were
sealed with plastic wrap and incubated at 22 º C (the
temperature employed for all simulations) for the desig-
nated times (24 h for TiO2, 48 h for CeO2 and 72 h for
Fe2O3). Plastic-wrapped paraffin molds containing trans-
ported suspensions were carefully removed from tubes,
flash frozen by immersing in liquid nitrogen for one mi-
nute, and moved to a pre-cooled (−30 °C) cryostat (CM-
3000, Leica Biosystems, Buffalo Grove, IL, USA). Plastic
wrap was removed and frozen paraffin broken away to
extract the solid pellets of suspension, which were then
mounted top side down in OCT fluid on specimen
chucks. Pellets were sectioned at 25 μm and ten sections
were combined per sample, representing a total thickness
of 250 μm each. Samples were allowed to thaw and their
ENM concentrations determined from optical absorbance
and standard curves obtained with a NanoDrop 2000
UV–vis spectrophotometer (Thermo Scientific, Wilming-
ton, DE, USA).
Distorted Grid model
Input and Initialization
Input data required by the DG model include the initial
mass concentration of the ENM, density of the bulk
ENM material, effective density of agglomerates (e.g.
from the VCM), height of the suspension column, the
size or size distribution of the suspended particles (i.e.
diameter and corresponding fraction of total solute for
each particle species j), media density and viscosity, and
temperature.
The vertical cylindrical column representing the cell
culture well is divided by n + 1 horizontal boundaries
into n compartments of equal height. The top and
bottom of the well are the ‘impermeable’ boundaries
1 and n + 1, respectively; thus each compartment i is
enclosed between boundaries i and i + 1. The initial
distribution of each particle species j is described by
assigning a value Ci,j to the mean concentration in
each compartment. Since the initial suspension is
homogeneous throughout the well, this is equal to
the initial concentration C0,j of species j in the well
for all cells. Thus,
Ci;j ¼ C0;j; 1≤i ≤ n ð4Þ
Modeling diffusion
According to Fick’s first law a substance flows from a re-
gion of higher concentration to a region of lower con-
centration at a rate (per unit cross-sectional area)
proportional to the magnitude of the concentration gra-
dient at the boundary of the two regions:
J ¼ −D ∂C
∂z
ð5Þ
where C is the concentration (kg m−3), z is the position
(m), and the proportionality constant D is the diffusion
coefficient (m2 s−1), which is defined by the Stokes-
Einstein equation (Eq. 2).
During a short time interval, Δt, the mass of solute
species j moving upward out of compartment i, and
across boundary i, Mout, can be represented as
Mout ¼ AΔtDi;j Ci−1;j−Ci;j
Δz
ð6Þ
where A is the cross-sectional area of the column, Di,j is
the diffusion coefficient of particle species j at boundary
DeLoid et al. Particle and Fibre Toxicology  (2015) 12:32 Page 14 of 20
i, Ci − 1,j and Ci,j are the concentrations of particle species
j in the two compartments, and Δz is the distance be-
tween the centers of the two compartments. Likewise,
the mass of particle species j moving upward into com-
partment i, across boundary i + 1, Min, is given as
Min ¼ AΔtDiþ1;j Ciþ1;j−Ci;j
Δz
ð7Þ
These mass movements of material into and out of a
compartment in single round of diffusion are depicted in
Additional file 1: Figure S1 b. The net change in concen-
tration of species j in compartment i, ΔCi,j can be
defined as
ΔCi;j ¼ Min þMoutAΔz ð8Þ
Substituting Eqs. 6 and 7 into Eq. 8, and simplifying
gives
ΔCi;j ¼ ΔtΔz2
 
Di;j Ci−1;j−Ci;j
 þ Diþ1;j Ciþ1;j−Ci;j   ð9Þ
Note that the cross-sectional area A cancels and is
thus not needed for this calculation. In each iteration of
the model, Eq. 9 is applied to each compartment, and
the new concentration of species j in compartment i
after time Δt is calculated as:
C
0
i;j ¼ Ci;j þ ΔCi;j ð10Þ
Although the diffusion coefficients for a given species j
at each boundary Di,j are considered identical for the
systems modeled here, this may not always be the case.
Here we have assumed that diffusion coefficients are in-
dependent of concentration and that possible cross-
diffusion coefficients are negligible. However, the model
has been implemented with an array of diffusion coeffi-
cients (one for each boundary) for each agglomerate spe-
cies j, allowing future accommodation of more complex
systems. The implementation and also includes an op-
tion to add a non-linear concentration dependence
factor for the diffusion coefficient, represented as
D
0
i;j ¼
Di;j
1þ kCi;j ; ð11Þ
where k is the concentration dependence factor. For all
simulations reported here the value of k was set to its
default value of 0. We also assume for polydisperse sus-
pensions that the concentrations of different species do
not affect diffusion coefficients of one another, and that
such systems can therefore be modeled by simultan-
eously but independently simulating transport of a each
species. We further assume that particles or agglomer-
ates do not dissociate and re-associate during transport,
and that surface charge effects (attraction and repulsion)
are negligible. However, the segmented, iterative design
of the model would allow such considerations to be ac-
commodated relatively easily, by adjusting concentra-
tions and diffusion coefficients at the end of each short
round of simulated transport.
Modeling sedimentation
The sedimentation velocity, vs, of a particle under gravity
is defined by Eq. 1. The sedimentation coefficient of a
particle, S, is defined as the ratio of a particle’s sedimen-
tation velocity to the acceleration applied to it. Thus, for
a particle sedimenting under gravity,
S ¼ vs=g ð12Þ
where g is the acceleration due to gravity. The down-
ward vertical displacement of a particle with sedimenta-
tion coefficient S in Δt seconds is given by
Δz ¼ SgΔt ð13Þ
In the previously-described method for simulation of
velocity sedimentation that is the basis for this model
[26–31], sedimentation was modeled by displacing com-
partment boundaries in the direction of sedimentation,
and subsequently re-calculating solute concentrations in
the bounded compartments. Because of this boundary
migration the model did not adequately handle the situ-
ation at the bottom of the cell (bottom of the well in our
model), since over the course of the simulation a num-
ber of boundaries would accumulate at the bottom of
the cell and collapse associated compartments. In our
model, since the concentration in the compartments at
the bottom of the cell are of the most interest, it was ne-
cessary to revise the sedimentation component of the
model so that solute (particles) could be moved be-
tween compartments without permanently moving
compartment boundaries. This is accomplished by cal-
culating, in each round of simulated sedimentation,
the distance by which, for each particle species j, each
compartment i would be displaced during the simula-
tion time interval Δt:
Δzi;j ¼ Si;jgΔt ð14Þ
where Δzi,j is the downward displacement of compart-
ment i, and Si,j is the sedimentation coefficient of par-
ticle species j at the center (along the z axis) of
compartment i. By the sedimentation of particle species
j into compartment i from compartment i − 1 above, the
concentration in compartment i is increased by the
product of the concentration in compartment i – 1 and
the fraction of the compartment height that is displaced
into compartment i:
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ΔCin ¼ Ci−1;j Δzi−1;jh
 
ð15Þ
where h is the height of a compartment. Likewise, by sedi-
mentation of particle species j out of compartment i, the
concentration in compartment i is decreased by
ΔCout ¼ Ci;j Δzi;jh
 
ð16Þ
The new concentration is thus calculated for compart-
ment i by adding ΔCin to, and subtracting ΔCout from its
previous concentration, which yields
C
0
i;j ¼ Ci−1;j
Δzi−1;j
h
 
þ Ci;j 1−Δzi;jh
 
ð17Þ
A single round of sedimentation for one compartment
is depicted in Additional file 1: Figure S1b. In order to pre-
vent compartment displacement in one iteration from
completely overtaking the next compartment for the user-
selected Δt, the displacement that would be experienced
by the particle species with the largest sedimentation coef-
ficient in that time is calculated at the outset of the simu-
lation. If that displacement is greater than h/2, then the
largest time step allowable (producing displacement h/2)
is calculated and used in place of the specified time step.
As with diffusion, although in the simulations described
here it was assumed that the sedimentation coefficients at
each boundary are identical, and that there is no depend-
ence of sedimentation coefficients on concentration, the
model is implemented with an array of sedimentation coef-
ficients (one per boundary per species) and allows the
introduction of concentration dependence. The sedimenta-
tion coefficient frequently varies in a non-linear way with
concentration [44]. This relationship is often described by:
S
0
i;j ¼
Si;j
1þ kCi;j ð18Þ
where k is a solute-dependent constant. For all simula-
tions reported here the value of k was set to its default
value of 0.
Iteration and output
The simulation proceeds by alternating rounds of diffu-
sion (Eqs. 9 and 10) and sedimentation (Eq. 17) of dur-
ation Δt until the selected cumulative time is obtained. At
user-selected intervals during the simulation, as well as
the end of simulation, the concentrations in each com-
partment, as well as derived mass, particle number and
surface area dose metrics are exported to an excel file.
Corrections to frictional coefficients
The DG model includes corrections to particle frictional
coefficients in the form of ratios of corrected to ideal
Stokes frictional coefficient, f/f 0. Dividing the diffusion co-
efficients and sedimentation velocities by these ratios pro-
vides the associated correction for transport calculations.
As particle size approaches the mean free path of the
media, λ, (≈ 2.5 × 10−10 m for water), slipping of solvent
molecules at the particle surface (where ideally solvent has
zero velocity) requires a correction referred to as the “slip”,
or Cunningham correction factor, Cc [45, 46], such that:
f =f 0 ¼ 1
Cc
ð19Þ
where
Cc ¼ 1þ λd 2:34þ 1:05e
−0:39d2λ
 	
ð20Þ
The magnitude of this correction for typical ENM parti-
cles and agglomerates is almost negligible (e.g. Cc ≈ 1.006
for d = 100 nm), and only becomes significant for particles
with diameters <5 nm (Cc ≈ 1.12 for d = 5 nm, and Cc ≈
1.30 for d = 2 nm). In the DG model this correction is ap-
plied by default unless otherwise specified by the user.
Additional corrections for non-spherical shape, solv-
ation, and surface roughness can also be included.
Whereas diameters obtained by DLS, being calculated
from measured diffusion coefficients using the Stokes-
Einstein equation (Eq. 2), are by definition hydro-
dynamic diameters (dH), which account for these effects,
diameters measured by other methods (TEM, TRPS)
may more accurately be considered diameters of ideal-
ized (unsolvated, smooth) spheres of equivalent volume
(dE). A correction of the form f/f
0 for non-spherical
shape, commonly referred to as a dynamic shape factor,
χ, can be specified in the model input either directly, or by
indicating one of four specific shapes for which χ is known
or can be calculated from known equations. These shapes
include a cube, for which χ = 1.08 [45], and a prolate el-
lipsoid, oblate ellipsoid and circular cylinder with a ratio
of major to minor axis length P = a/b, for which χ can be
calculated as follows [44]:
Prolate ellipsoid : χ ¼ P
−1=3 P2−1
 1=2
ln P þ P2−1 1=2h i ð21Þ
Oblate ellipsoid : χ ¼ P
2−1
 1=2
P2=3tan−1 P2−1
 1=2h i ð22Þ
Circular cylinder : χ ¼ 2=3ð Þ
1=3P2=3
ln 2Pð Þ−0:3 ð23Þ
In most cases these corrections are relatively small.
For example, for a prolate ellipsoid, oblate ellipsoid and
cylinder with P = 3, χ = 1.11, 1.10 and 1.27, respectively.
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For other shapes and solvation and roughness factors,
estimation of f/f 0 is a complex topic beyond the scope of
this paper. The DG model nevertheless provides options
for user-specified shape, solvation and roughness correc-
tion factors.
Calculation of volume-weighted hydrodynamic diameter
distribution and average
The volume-weighted fraction, fV,i, for each diameter,
dH,i, corresponding to the number fraction, fN,i, obtained
from DLS were calculated as
f V;i ¼
f N;idH;i
3X
i
f N;idH;i
3
ð24Þ
and the volume-weighted average hydrodynamic
diameter, 〈dH〉V, as
< dH >V ¼
X
i
f V;idH;i ð25Þ
Calculation of particle number and surface concentrations
The effective density of an ENM agglomerate, ρEV, which
we can measure by the VCM method, can be expressed
as a weighted average of the media and raw nanomater-
ial densities:
ρEV ¼ f V;NMρNM þ 1−f V;NM
 	
ρm ð26Þ
where fV,NM is the volume fraction of the agglomerate
consisting of the nanomaterial, ρNM is the density of raw
nanomaterial, and ρm is the density of the media. Solving
for fV,NM yields
f V;NM ¼
ρEV−ρm
ρNM−ρm
ð27Þ
The volume concentration of raw nanomaterial,
CV,NM, can be expressed as the product of fV,NM and the
volume concentration of the agglomerate, CV,agg,
which is also equivalent to the mass concentration of
raw nanomaterial, CNM, divided by its density:
CV;NM ¼ CV;aggf V;NM ¼
CNM
ρNM
ð28Þ
Dividing through by fV,NM yields
CV;agg ¼ CNM
ρNM f V;NM
ð29Þ
Dividing by the volume of a single agglomerate, πdH
3 /6
(assuming spherical shape) gives the agglomerate par-
ticle number concentration as
CN;agg ¼ 6CNM
πd3HρNM f V;NM
ð30Þ
where dH is the hydrodynamic diameter of the agglomer-
ate. Multiplying this by the surface area of a spherical
agglomerate, πdH
2 , yields the agglomerate surface area
concentration,
CS;agg ¼ 6CNMdHρNM f V;NM
ð31Þ
Finally, assuming that agglomerates are homogeneous
(i.e. that primary nanomaterial particles are evenly distrib-
uted throughout the agglomerate), the fraction of agglom-
erate surface made up by nanomaterial surface is identical
to the volume fraction of nanomaterial in the agglomerate,
namely fV,NM, and the nanomaterial surface concentration,
CS,NM is the product of CS,agg and fV,NM. Thus,
CS;NM ¼ 6CNMdHρNM
ð32Þ
Implementation of the Langmuir isotherm adsorption
Binding of agglomerates implemented as a Langmuir
isotherm adsorption process, in which the equilibrium
dissociation constant, KD, is defined as
KD ¼ kdka ¼
ð1−θÞ½P
θ
ð33Þ
where kd and ka are the rate constants for desorption
and adsorption, θ is the surface coverage, defined as the
fraction of surface sites occupied by adsorbed particles,
and [P] is the molar concentration of particles [31]. Re-
arranging Eq. 33, the fraction of surface sites occupied,
θ, can be expressed as
θ ¼ P½ 
KD þ P½  ð34Þ
To implement Langmuir isotherm adsorption in the
DG model, at the end of each round of simulated diffu-
sion and sedimentation, the particle (agglomerate) molar
concentration [P] (mol L−1) in the bottom compartment
is calculated from the particle (agglomerate) mass con-
centration CP as
½P ¼ 10
−3  Cp
NAρEV
4
3πr
3
  ð35Þ
where NA is Avagadro’s number, ρEV is the effective dens-
ity (agglomerate density) and r is the particle radius. The
fraction of surface sites occupied is then calculated from
Eq. 34. The factor of 10−3 in the numerator provides con-
version of units from moles m−3 to moles L−3. Because the
nature and distribution of the surface adsorption sites
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are hypothetical in our model, we assume that the fraction
of sites occupied is equivalent to the fraction of surface
area occupied. Particles available for adsorption are lim-
ited to those present in the bottom simulation compart-
ment with a height of Δz. The fraction of bottom surface
that can be covered by the particles within this compart-
ment can thus be estimated as
θavail ¼ ΔzCpAm ð36Þ
where Am is the cross-sectional area per mass of particle:
Am ¼ 34rρEV
ð37Þ
The fraction of particles in the bottom compartment
that are bound is then calculated as
Fb ¼ θ
θavail
for
θ
θavail
≤1:0; or Fb ¼ 1:0 for θ
θavail
> 1:0
ð38Þ
The concentration (mg cm−3) of particle bound within
the bottom compartment is then calculated as
Cb ¼ FbCp ð39Þ
and the concentration of free particle is
Cfree ¼ ð1−FbÞCp ð40Þ
Since bound particles do not contribute to the concen-
tration gradient driving diffusion, the concentration of
free particles is used for calculating diffusion in the
bottom compartments.
Computational Fluid Dynamics model
For CFD mass transport predictions, the Eulerian–La-
grangian solution of the Navier–Stokes equation was
used to model the fluid phase as a continuum, while
treating the dispersed particles as a discrete phase, and
tracking each particle in the Lagrangian coordinate sys-
tem within the calculated flow field. Particle-to-particle
interactions were neglected and it was assumed that the
dispersed phase occupied a much smaller volume frac-
tion than the fluid phase. The Eulerian–Lagrangian ap-
proach calculates the particle trajectories by integrating
the forces acting on each particle in a Lagrangian refer-
ence frame [47]. In the corresponding force balance
equation, the particle inertia is equal to the sum of other
forces acting on the particle:
dup
dt
¼ FD

u
→−u
→
p

þ g
→ 
ρp−ρ

ρp
þ F→ ð41Þ
Here, F
→
is an additional acceleration term, g
→
is gravita-
tional acceleration, ρ is the fluid density, ρp is the
particle density, u
→
is the fluid phase velocity, u→p is the
particle velocity, and FD

u→ −u→p

is the drag force per
unit particle mass, the general expression for which is
FD ¼ 18μ
ρpd
2
p
CDRe
24
ð42Þ
Here, μ is the fluid viscosity, dp is the particle diam-
eter, CD is a drag correction factor, and Re is the relative
Reynolds number, which is defined as:
Re ¼
ρdp u
→
p− u
→



 



μ
ð43Þ
In the model design employed in this work, laminar dif-
fusion, Brownian motion and gravitational force were con-
sidered, while other forces, such as thermophoretic Force
and Saffman’s lift Force were neglected. Because dp < 500
nm, Brownian motion was included in the additional force
term (F
→
) [48, 49], and the Stokes-Cunningham Drag Law,
which accounts for non-zero relative velocity of fluid at
the particle surface (“slip”), was chosen [50]. In this spe-
cific drag law, FD is defined as:
FD ¼ 18μ
ρpd
2
pCc
ð44Þ
where the factor Cc is the Cunningham correction factor,
as defined above (Eq. 20). Note that Cc in the denomin-
ator here replaces the CDRe/24 term in the general drag
force expression (Eq. 42).
In this study, the simulation domain encompassed as a
cylinder space with constant dimensions of 1.5 mm
diameter and 1.0 mm height. To reduce the computa-
tional resources required, transport was modeled within
a π/4 radian sector of the circular cylinder representing
the cell culture well. A structured grid with a total of
3,586,000 elements was employed to represent the com-
putational spatial domain. Grid independency analysis
was carried out by varying grid numbers in all three di-
mensions. Performance at different grid aspect ratios,
ranging from 1.0 to 3.0 was analyzed to minimize com-
putational resources. For the final simulations, grid sizes
of 2.5 μm and 5.0 μm were selected for z direction and
x,y directions of Cartesian coordinates, respectively,
resulting in the uniform grid aspect ratio of 2.0.
In the sector-shaped simulation domain, a symmetry
boundary condition was employed for the cutting planes
(flat vertical sector surfaces). All other surfaces, including
the top, bottom and outer curved cylinder surfaces, were
modeled as no-slip wall boundaries with zero roughness
and a constant temperature of 22 °C. A reflective boundary
condition was imposed at all walls for the discrete phase
DeLoid et al. Particle and Fibre Toxicology  (2015) 12:32 Page 18 of 20
mode [47, 50], with a default constant value of 1.0 for both
normal and tangential coefficient of restitution [47].
A three-dimensional structured mesh with the finite
volume method and double precision option were utilized
to discretize the computational domain, and to describe
the mass and momentum transport for each cell. The
SIMPLE algorithm was used to solve the pressure and vel-
ocity components. Spatial discretizations for momentum
and energy equations employed the second-order upwind
scheme. Time-dependent terms were interpolated using
the implicit second-order interpolation scheme. All parti-
cles were injected at t = 0 and assigned an initial velocity
magnitude of 0.0 m s−1.
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